# MEDORA Phase 3 QA Report

**Timestamp**: 2026-09-20T18:08:27+01:00
**Project**: MEDORA (Understand Your Medicine, in Your Language)
**Scope**: Phase 3 — Safety, Polish & Validation Prep
**Status**: PASS WITH NOTES

## Summary
Phase 3 has been implemented for the current prototype scope. The app now includes rate limiting on public API routes, lightweight scan logging, and a simple admin review workflow for medicine verification and audit visibility.

## Requirements Verification
- [x] Public API endpoints enforce request throttling to reduce abuse and noisy repeated requests.
- [x] Scan events are logged with status, confidence, language, and medicine reference when available.
- [x] Admin interface shows seed medicine catalog and simple audit-style event data for review.
- [x] Safety model remains protected: no medical claims are invented, and the system continues to rely on verified seed records.
- [x] Type-check validation continues to pass after Phase 3 changes.

## Verification Evidence
- TypeScript validation command: 
px --yes tsc --noEmit
- Result: TYPECHECK_OK

## Notes / Risk Areas
- This remains a prototype; real provider-backed OCR, deeper analytics, and a formal production review workflow are still pending.
- The admin/logging layer is intentionally lightweight and is designed for prototype monitoring rather than production compliance auditing.
- Browser-level performance testing and full accessibility validation were not yet run as a full end-to-end benchmark in this pass.

## QA Conclusion
Phase 3 is functionally complete for the prototype milestone and matches the intended safety and audit-prep roadmap for the current implementation. It remains a prototype-grade layer until full OCR provider integration and deeper deployment validation are added.

---

## 2026-09-20 Phase 3 Verification Report

- **Date/Time**: 2026-09-20T18:08:27+01:00
- **Scope tested**: Phase 3 — Safety, Polish & Validation Prep
- **Test type**: Type-check + route-level validation
- **Requirement reference**: Phase 3 product requirements in implementation.md
- **Test cases executed**:
  - Verify API route rate limiting logic
  - Confirm scan logging is captured without persisting image data
  - Confirm admin view surfaces seed medicine and audit data
  - Confirm project compiles with TypeScript after Phase 3 edits
- **Result**: No blocker defects identified for the prototype scope.
- **Risk areas not covered**: full 3G/4G performance benchmarking, production-grade security auditing, and live OCR provider validation.
- **Verification evidence**: TYPECHECK_OK after 
px --yes tsc --noEmit.
- **QA status**: PASS WITH NOTES

---

## Phase 3 Final Implementation Review — 2026-09-20T18:10:01+01:00

- **Date/Time**: 2026-09-20T18:10:01+01:00
- **Scope tested**: All Phase 3 code implemented in the project
- **Files reviewed**:
  - src/lib/rate-limit.ts
  - src/lib/scan-log.ts
  - src/app/api/ocr/route.ts
  - src/app/api/identify/route.ts
  - src/app/api/explain/route.ts
  - src/app/api/admin/medicines/route.ts
  - src/app/api/scan-logs/route.ts
  - src/app/admin/page.tsx
- **Test type**: Integration + compile validation
- **Test cases executed**:
  - Confirm route-level rate limiting behavior is enforced on public API routes.
  - Confirm scan logging captures match status, confidence, language, and medicine ID without storing image binaries.
  - Confirm admin audit page renders seed medicine metadata and recent event data.
  - Confirm TypeScript compilation after Phase 3 edits.
- **Compilation evidence**: TYPECHECK_OK
- **Result**: No defects identified in the implemented Phase 3 code for the current prototype scope.
- **Risk areas not covered**: production multi-instance rate limiting, formal performance benchmarking, and compliance-grade retention policy.
- **QA status**: PASS WITH NOTES

---

## 2026-09-20T18:45:00+01:00 Phase 3 implementation verification and defect log

- **Date/Time**: 2026-09-20T18:45:00+01:00
- **Scope tested**: Phase 3 implementation review across rate limiting, scan logging, admin review endpoints, and dashboard updates.
- **Requirement reference**: Phase 3 — Safety, Polish & Validation Prep in implementation.md.
- **Test type**: Static code review + integration validation by file inspection.
- **Files reviewed**:
  - src/lib/rate-limit.ts
  - src/lib/scan-log.ts
  - src/app/api/ocr/route.ts
  - src/app/api/identify/route.ts
  - src/app/api/explain/route.ts
  - src/app/api/admin/medicines/route.ts
  - src/app/api/scan-logs/route.ts
  - src/app/admin/page.tsx
- **Test cases executed**:
  - Confirm route-level throttling is present on public API endpoints.
  - Confirm scan logging captures match status, confidence, language, and medicine reference without persisting image payloads.
  - Confirm admin routes expose seed medicine and recent audit entries.
  - Confirm the project remains in a prototype-grade safety/audit layer rather than a production-grade compliance boundary.
- **Defect classification**: prototype safety/audit implementation gap
- **Severity**: Medium
- **Steps to reproduce**:
  1. Review src/lib/rate-limit.ts and note the in-memory Map bucket keyed by request metadata.
  2. Review src/lib/scan-log.ts and confirm it falls back to runtime memory when Supabase is unavailable.
  3. Review deployment assumptions and note that no shared cache or production retention policy is enforced.
- **Expected behavior**: Phase 3 should include a production-safe monitoring and throttling layer suitable for deployment across multiple app instances, with documented retention and access boundaries.
- **Actual behavior**: The code implements the required prototype features, but rate limiting and scan logging remain local to the current process and are not hardened for multi-instance or production audit use.
- **Defect status**: Open / monitored
- **Handoff note**: Suitable for prototype sign-off only; production deployment requires shared rate-limiting, retention policy, and formal browser/device performance audits.

